24.20USD-2.77%Mkt Cap: 928.75M $P/E: —2d ago
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the ac…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap928.75M $
Enterprise Value825.62M $
Revenue (TTM)101.96M $
Gross Profit78.27M $
Net Income (TTM)-53.41M $
Revenue/Share2.725 USD
Last Price24.20 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees327
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-15.81
PEG—
EV/EBITDA-12.00
EV/Revenue8.10
P/S9.15
P/B7.24
EPS (TTM)-1.72
EPS (Forward)-1.54
52W Range
10.8592% of range25.33
52W High25.33 USD
52W Low10.85 USD
Profitability
Gross Margin87.89%
Oper. Margin-71.11%
EBITDA Margin-67.48%
Profit Margin-59.97%
ROE-34.38%
ROA-27.28%
Growth
Revenue Growth32.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-40.81M $
CapEx (TTM)767.00K $
FCF Margin-32.41%
FCF Yield-3.56%
Net Debt-107.35M $
Net Debt/EBITDA1.56
Balance Sheet
Debt/Equity0.14
Current Ratio9.18
Quick Ratio8.45
Book Value/Sh3.357 USD
Cash/Share3.368 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)27.29 USD
Upside (mean)+12.8%
Target Range24.00 USD – 32.00 USD
$24.00+12.8% to mean$32.00
# Analysts7
Ownership
Shares Out.38.38M
Float26.52M
Insiders12.03%
Institutions88.71%
Short Interest
Short Ratio5.5d
Short % Float8.11%
Short % Out.5.28%
Shares Short2.02M
Short (prev mo.)1.98M
Technical
SMA 5019.41 (+24.7%)
SMA 20019.10 (+26.7%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)404.42K
Avg Vol (10d)583.89K
Technical Indicators
RSI (14)82.0
MACD1.4321
MACD Signal0.6959
MACD Hist.+0.7362
BB Upper24.99 USD
BB Middle19.53 USD
BB Lower14.07 USD
BB Width55.87%
ATR (14)1.011 USD
Vol Ratio (20d)1.85x